Compounds > spiperone
Page last updated: 2024-08-16

spiperone and g(m1) ganglioside

spiperone has been researched along with g(m1) ganglioside in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's3 (42.86)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hadjiconstantinou, M; Neff, NH; Weihmuller, F1
Agnati, LF; Benfenati, F; Calza, L; Cavicchioli, L; Fuxe, K; Goldstein, M; Toffano, G1
Agnati, LF; Battistini, N; Benfenati, F; Cavicchioli, L; Fuxe, K; Toffano, G1
Augustin, W; Sabel, BA; Schröder, H; Schröder, U1
Sabel, BA; Schroeder, H; Schroeder, U1
De Lucia, R; Flório, JC; Frussa-Filho, R; Palermo-Neto, J; Tufik, S; Vital, MA1
Pope-Coleman, A; Schneider, JS; Tinker, JP1

Other Studies

7 other study(ies) available for spiperone and g(m1) ganglioside

ArticleYear
Treatment with GM1 ganglioside reverses dopamine D-2 receptor supersensitivity induced by the neurotoxin MPTP.
    European journal of pharmacology, 1989, Sep-13, Volume: 168, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; G(M1) Ganglioside; Kinetics; Male; Mice; Neurotoxins; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone; Tritium

1989
Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting.
    Acta physiologica Scandinavica, 1983, Volume: 119, Issue:4

    Topics: Animals; Cell Survival; Dendrites; G(M1) Ganglioside; Gangliosides; Male; Nerve Degeneration; Nerve Endings; Nerve Regeneration; Neurons; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Substantia Nigra; Synapses; Tyrosine 3-Monooxygenase

1983
Selective modulation of 3H-spiperone labeled 5-HT receptors by subchronic treatment with the ganglioside GM1 in the rat.
    Acta physiologica Scandinavica, 1983, Volume: 117, Issue:2

    Topics: Animals; Butyrophenones; Cell Membrane; Cerebral Cortex; Corpus Striatum; G(M1) Ganglioside; Gangliosides; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Spiperone

1983
Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 271, Issue:3

    Topics: Animals; Corpus Striatum; Dose-Response Relationship, Drug; G(M1) Ganglioside; Gangliosides; Haloperidol; Male; Motor Activity; Rats; Rats, Wistar; Receptors, Dopamine D2; Spiperone

1994
The role of striatal glutamatergic system in haloperidol-induced dopamine receptor supersensitivity and effects of monosialoganglioside GM1.
    Pharmacology, biochemistry, and behavior, 1997, Volume: 58, Issue:4

    Topics: Animals; Aspartic Acid; Dopamine Antagonists; G(M1) Ganglioside; Glutamic Acid; Haloperidol; Male; Neostriatum; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Glutamate; Spiperone

1997
Effects of haloperidol and GM1 ganglioside treatment on striatal D2 receptor binding and dopamine turnover.
    Life sciences, 1998, Volume: 62, Issue:13

    Topics: Animals; Corpus Striatum; Dopamine; Dopamine Antagonists; Drug Administration Schedule; Drug Synergism; G(M1) Ganglioside; Haloperidol; Kinetics; Male; Rats; Rats, Wistar; Receptors, Dopamine D2; Spiperone; Tritium

1998
Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergic markers in the striatum of parkinsonian monkeys.
    Synapse (New York, N.Y.), 2000, Volume: 36, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzazepines; Binding Sites; Dopamine Agents; Dopamine Antagonists; Dopamine Uptake Inhibitors; G(M1) Ganglioside; Mazindol; Neostriatum; Parkinsonian Disorders; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Recovery of Function; Saimiri; Spiperone; Synapses

2000